| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $2.4M | +106.5% |
| SG&A Expense | $6.5M | +96.4% |
| Operating Income | -$8.9M | -99.0% |
| Interest Expense | $147K | -77.5% |
| Income Tax | $0 | — |
| Net Income | -$16.5M | -221.9% |
| EPS (Basic) | -$0.68 | -277.8% |
| EPS (Diluted) | -$0.68 | -277.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $9.2M | +304.4% |
| Accounts Receivable | $300K | +0.0% |
| Current Assets | $9.2M | +251.0% |
| Total Assets | $11.8M | +145.0% |
| Current Liabilities | $9.2M | +29.8% |
| Total Liabilities | $10.6M | +19.8% |
| Stockholders' Equity | $1.3M | +131.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$6.4M | -57.4% |
| Capital Expenditures | $495K | — |
| Investing Cash Flow | -$495K | — |
| Financing Cash Flow | $13.8M | +132.8% |
| Free Cash Flow | -$6.9M | — |